Position in NEOG
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,980,306
-$6,658,127 QoQ
Shares Held
320,808
-53.5% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NEOG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,649,670,055 across 35 Medical Devices names. NEOG ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
13,891,668 | $871,702,167 | |
| 2 | ABT |
Abbott Laboratories
|
5,522,222 | $566,966,532 | |
| 3 | SYK |
Stryker Corp
|
1,555,638 | $511,167,090 | |
| 4 | MDT |
Medtronic plc
|
4,659,425 | $403,739,176 | |
| 5 | PODD |
Insulet Corp
|
1,229,928 | $258,088,091 | |
| 6 | DXCM |
Dexcom Inc
|
2,545,103 | $159,832,468 | |
| 7 | EW |
Edwards Lifesciences Corp
|
1,890,859 | $151,419,988 | |
| 8 | PEN |
Penumbra Inc
|
400,160 | $131,400,539 |
All Filings in NEOG
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,980,306 | 320,808 | Shares | Defined | 2026-05-14 | |
| 2022-09-30 | $9,638,433 | 689,938 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,485,678 | 103,183 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $9,094,936 | 209,416 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,778,226 | 82,064 | Shares | Defined | 2021-08-13 | |
| 2020-09-30 | $974,212 | 24,900 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $221,160 | 5,700 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||